Title
The status of cryptococcosis in latin America
Date Issued
01 July 2018
Access level
open access
Resource Type
review
Author(s)
Firacative C.
Lizarazo J.
Illnait-Zaragozí M.T.
Castañeda E.
Arechavala A.
Córdoba S.
Mazza M.
Taverna C.S.
Isla G.
Chiapello L.
Vergara M.L.S.
Melhem M.S.C.
Szeszs M.W.
Martins M.D.A.
Bonfietti L.X.
de Oliveira R.A.
de Oliveira L.
Santos D.C.S.
Lazera M.S.
Wanke B.
Díaz M.C.
Escandón P.
Noguera M.C.
Andreu C.M.F.
CastrilLón L.
Dolande M.
Ferrara G.
Publisher(s)
Fundacao Oswaldo Cruz
Abstract
Cryptococcosis is a life-threatening fungal infection caused by the encapsulated yeasts Cryptococcus neoformans and C. gattii, acquired from the environment. In Latin America, as occurring worldwide, C. neoformans causes more than 90% of the cases of cryptococcosis, affecting predominantly patients with HIV, while C. gattii generally affects otherwise healthy individuals. In this region, cryptococcal meningitis is the most common presentation, with amphotericin B and fluconazole being the antifungal drugs of choice. Avian droppings are the predominant environmental reservoir of C. neoformans, while C. gattii is associated with several arboreal species. Importantly, C. gattii has a high prevalence in Latin America and has been proposed to be the likely origin of some C. gattii populations in North America. Thus, in the recent years, significant progress has been made with the study of the basic biology and laboratory identification of cryptococcal strains, in understanding their ecology, population genetics, host-pathogen interactions, and the clinical epidemiology of this important mycosis in Latin America.
Volume
113
Issue
7
Language
English
OCDE Knowledge area
Farmacología, Farmacia
Micología
Subjects
Scopus EID
2-s2.0-85049645489
PubMed ID
Source
Memorias do Instituto Oswaldo Cruz
ISSN of the container
00740276
Sources of information:
Directorio de Producción Científica
Scopus